Biocon’s Mazumdar-Shaw pledges cheaper insulin for low income countries

Low and middle income countries would be able to purchase recombinant human insulin at a fraction of the current cost under a commitment by the founder of Indian biopharma Biocon, Kiran Mazumdar-Shaw.

The current median price

Read the full 353 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE